{"entity":{"type":"insider","cik":"0001559209","url":"/insider/0001559209","json_url":"/insider/0001559209.json","name":"Williams Glen","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":4,"first":"2014-06-26","last":"2015-06-09","span_basis":"filed_date"},"name_variants":[{"name":"Williams Glen","source":"filing","n_filings":4,"first_seen":"2014-06-26","last_seen":"2015-06-09"}],"transactions":[{"id":8577610,"accession":"0001209191-15-051540","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-15-051540","line_url":"/filing/0001209191-15-051540","is_derivative":false,"issuer_cik":"0000911326","issuer_name":"SYNAGEVA BIOPHARMA CORP","issuer_ticker":"GEVA","issuer_name_source":null,"issuer_url":"/issuer/0000911326","owner_cik":"0001559209","owner_name":"Williams Glen","owner_display_name":"Williams Glen","owner_url":"/insider/0001559209","role":"Officer (SVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12916.0,"shares_display":"12,916","price_per_share":214.91510684422423,"price_display":"214.92","price_state":"stated","total_value":2775843.52,"total_display":"2,775,843.52","total_whole":"2,775,844","shares_owned_after":28488.0,"shares_owned_after_display":"28,488","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-08","filed_date":"2015-06-09","scope":"insider","n_lines":2},{"id":8152528,"accession":"0001246360-15-002048","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001246360-15-002048","line_url":"/filing/0001246360-15-002048","is_derivative":false,"issuer_cik":"0000911326","issuer_name":"SYNAGEVA BIOPHARMA CORP","issuer_ticker":"GEVA","issuer_name_source":null,"issuer_url":"/issuer/0000911326","owner_cik":"0001559209","owner_name":"Williams Glen","owner_display_name":"Williams Glen","owner_url":"/insider/0001559209","role":"Officer (SVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1666.0,"shares_display":"1,666","price_per_share":205.62085234093638,"price_display":"205.62","price_state":"stated","total_value":342564.34,"total_display":"342,564.34","total_whole":"342,564","shares_owned_after":1468.0,"shares_owned_after_display":"1,468","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-06","filed_date":"2015-05-08","scope":"insider","n_lines":5},{"id":8728653,"accession":"0001246360-15-001760","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001246360-15-001760","line_url":"/filing/0001246360-15-001760#line-6","is_derivative":false,"issuer_cik":"0000911326","issuer_name":"SYNAGEVA BIOPHARMA CORP","issuer_ticker":"GEVA","issuer_name_source":null,"issuer_url":"/issuer/0000911326","owner_cik":"0001559209","owner_name":"Williams Glen","owner_display_name":"Williams Glen","owner_url":"/insider/0001559209","role":"Officer (SVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":39863.0,"shares_display":"39,863","price_per_share":96.08,"price_display":"96.08","price_state":"stated","total_value":3830037.04,"total_display":"3,830,037.04","total_whole":"3,830,037","shares_owned_after":468.0,"shares_owned_after_display":"468","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-08","filed_date":"2015-04-09","scope":"insider"},{"id":8728645,"accession":"0001246360-15-001760","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001246360-15-001760","line_url":"/filing/0001246360-15-001760#line-3","is_derivative":false,"issuer_cik":"0000911326","issuer_name":"SYNAGEVA BIOPHARMA CORP","issuer_ticker":"GEVA","issuer_name_source":null,"issuer_url":"/issuer/0000911326","owner_cik":"0001559209","owner_name":"Williams Glen","owner_display_name":"Williams Glen","owner_url":"/insider/0001559209","role":"Officer (SVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2769.0,"shares_display":"2,769","price_per_share":96.04,"price_display":"96.04","price_state":"stated","total_value":265934.76,"total_display":"265,934.76","total_whole":"265,935","shares_owned_after":468.0,"shares_owned_after_display":"468","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-07","filed_date":"2015-04-09","scope":"insider"},{"id":6621529,"accession":"0001246360-14-003064","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001246360-14-003064","line_url":"/filing/0001246360-14-003064#line-3","is_derivative":false,"issuer_cik":"0000911326","issuer_name":"SYNAGEVA BIOPHARMA CORP","issuer_ticker":"GEVA","issuer_name_source":null,"issuer_url":"/issuer/0000911326","owner_cik":"0001559209","owner_name":"Williams Glen","owner_display_name":"Williams Glen","owner_url":"/insider/0001559209","role":"Officer (SVP, Technical Operations)","role_mark":"O","role_mark_label":"Officer (SVP, Technical Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Technical Operations","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":108.02,"price_display":"108.02","price_state":"stated","total_value":75614.0,"total_display":"75,614.00","total_whole":"75,614","shares_owned_after":266.0,"shares_owned_after_display":"266","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-25","filed_date":"2014-06-26","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":10,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000911326","name":"SYNAGEVA BIOPHARMA CORP","url":"/issuer/0000911326","role":"Officer (SVP, Technical Operations)","n_filings":4,"first_seen":"2014-06-26","last_seen":"2015-06-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001559209","retrieved_at":"2026-08-26T09:44:27+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}